Learning which foods to eat and avoid on Ozempic will maximize your weight loss results while minimizing uncomfortable side effects
Mounjaro (tirzepatide) is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus in adults
The Berry Street platform simplifies the connection and payment process
Achieving Consistent Hydration To help you stay consistently hydrated, consider the following strategies: Set Reminders: Sometimes, you may forget to drink water
GLP-1 receptor agonists achieve weight loss through several mechanisms: Slowing gastric emptying, which promotes feelings of fullness Reducing appetite by acting on brain centres that control hunger Improving insulin secretion and reducing glucagon release Potentially affecting food reward pathways in the brain According to NICE Technology Appraisal guidance (TA875 for semaglutide/Wegovy and TA664 for liraglutide/Saxenda), these medications may be considered for weight management in adults with a BMI of at least 35 kg/m (or 32.5 kg/m for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean family backgrounds) with at least one weight-related comorbidity
